UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.117

Sortiert nach

Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials

Schizophrenia bulletin, 2014-01, Vol.40 (1), p.192-213

2014

Link zum Volltext

Verfügbarkeit prüfen

Auditory hallucinations across the lifespan: a systematic review and meta-analysis

Psychological medicine, 2018-04, Vol.48 (6), p.879-888

2018

Link zum Volltext

Verfügbarkeit prüfen

Physical illness and schizophrenia: a review of the literature

Acta Psychiatrica Scandinavica, 2007-11, Vol.116 (5), p.317-333

2007

Link zum Volltext

Verfügbarkeit prüfen

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

Molecular psychiatry, 2013-01, Vol.18 (1), p.53-66

2013

Link zum Volltext

Verfügbarkeit prüfen

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

Molecular psychiatry, 2009-04, Vol.14 (4), p.429-447

2009

Link zum Volltext

Verfügbarkeit prüfen

Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method

Schizophrenia bulletin, 2014-03, Vol.40 (2), p.314-326

2014

Link zum Volltext

Verfügbarkeit prüfen

Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials

Acta psychiatrica Scandinavica, 2015-03, Vol.131 (3), p.185-196

2015

Link zum Volltext

Verfügbarkeit prüfen

Second-generation antipsychotics for schizophrenia: can we resolve the conflict?

Psychological medicine, 2009-10, Vol.39 (10), p.1591-1602

2009

Link zum Volltext

Verfügbarkeit prüfen

Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis

Acta psychiatrica Scandinavica, 2018-10, Vol.138 (4), p.281-288

2018

Link zum Volltext

Verfügbarkeit prüfen

S.05.03 Atypical antipsychotics in bipolar disorder and schizophrenia: similarities and discrepancies

European neuropsychopharmacology, 2013-10, Vol.23, p.S117-S118

Leucht, S

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: a systematic review and network meta‐analysis

Acta psychiatrica Scandinavica, 2020-07, Vol.142 (1), p.6-17

2020

Link zum Volltext

Verfügbarkeit prüfen

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta‐analysis

Acta psychiatrica Scandinavica, 2018-06, Vol.137 (6), p.450-458

2018

Link zum Volltext

Verfügbarkeit prüfen

The Concepts of Remission and Recovery in Schizophrenia

Pharmacopsychiatry, 2006-09, Vol.39 (5), p.161-170

2006

Link zum Volltext

Verfügbarkeit prüfen

Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

Schizophrenia bulletin, 2009-03, Vol.35 (2), p.443-457

2009

Link zum Volltext

Verfügbarkeit prüfen

No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review

Acta psychiatrica Scandinavica, 2020-05, Vol.141 (5), p.401-409

2020

Link zum Volltext

Verfügbarkeit prüfen

C.13.03 Translating the evidence on the clinical benefits of antipsychotics for routine practice

European neuropsychopharmacology, 2012-10, Vol.22, p.S451-S451

Leucht, S

2012

Link zum Volltext

Verfügbarkeit prüfen

A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

European neuropsychopharmacology, 2021-07, Vol.48, p.49-88

2021

Link zum Volltext

Verfügbarkeit prüfen

Equipercentile linking of the BPRS and the PANSS

European neuropsychopharmacology, 2013-08, Vol.23 (8), p.956-959

2013

Link zum Volltext

Verfügbarkeit prüfen

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

Acta Psychiatrica Scandinavica, 2009-02, Vol.119 (s438), p.7-14

2009

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research

Schizophrenia bulletin, 2015-05, Vol.41 (3), p.574-583

2015

Link zum Volltext

Verfügbarkeit prüfen

Shared decision making in psychiatry

Acta psychiatrica Scandinavica, 2003-06, Vol.107 (6), p.403-409

2003

Link zum Volltext

Verfügbarkeit prüfen

Shared decision making for in-patients with schizophrenia

Acta Psychiatrica Scandinavica, 2006-10, Vol.114 (4), p.265-273

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategies in case of non-response in schizophrenia: increasing the antipsychotic dose or switching the antipsychotic drug versus continuation of the same antipsychotic dose or drug

European neuropsychopharmacology, 2016-10, Vol.26, p.S562-S562

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

Schizophrenia research, 1999-01, Vol.35 (1), p.51-68

1999

Link zum Volltext

Verfügbarkeit prüfen

Second-generation antipsychotics and constipation: a review of the literature

European psychiatry, 2011-01, Vol.26 (1), p.34

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.008)
Mit Volltextzugriff
(964)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(662)
Life Sciences & Biomedicine
(619)
Humans
(525)
Psychiatry
(369)
Schizophrenia
(240)
Schizophrenia - Drug Therapy
(209)
Antipsychotic Agents - Therapeutic Use
(178)
Female
(172)
Adult
(156)
Male
(155)
Biological And Medical Sciences
(140)
Medical Sciences
(126)
Randomized Controlled Trials As Topic
(124)
Treatment Outcome
(120)
Antipsychotics
(104)
Middle Aged
(100)
Psychology. Psychoanalysis. Psychiatry
(99)
Neurosciences & Neurology
(93)
Antipsychotic Agents - Adverse Effects
(89)
Orthopedics
(85)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials

Auditory hallucinations across the lifespan: a systematic review and meta-analysis

Physical illness and schizophrenia: a review of the literature

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method

Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials

Second-generation antipsychotics for schizophrenia: can we resolve the conflict?

Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis

S.05.03 Atypical antipsychotics in bipolar disorder and schizophrenia: similarities and discrepancies

Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: a systematic review and network meta‐analysis

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta‐analysis

The Concepts of Remission and Recovery in Schizophrenia

Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review

C.13.03 Translating the evidence on the clinical benefits of antipsychotics for routine practice

A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

Equipercentile linking of the BPRS and the PANSS

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research

Shared decision making in psychiatry

Shared decision making for in-patients with schizophrenia

Treatment strategies in case of non-response in schizophrenia: increasing the antipsychotic dose or switching the antipsychotic drug versus continuation of the same antipsychotic dose or drug

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

Second-generation antipsychotics and constipation: a review of the literature

Suchergebnisse filtern